Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Henlius 2023 Annual Results: Revenue surpassed RMB5.39 billion with a net profit RMB546 million, first full-year profitability achieved 2024-03-21 19:47
Biosion to Present Three Posters at the 2024 AACR Meeting 2024-03-21 19:00
HanAll Biopharma Reports Full-Year 2023 Financial Results and Provides Business Update 2024-03-21 19:00
Mabwell Presented IDDC™ Platform Technology and ADC Drug Development Achievements at the 14th World ADC London 2024-03-21 14:11
SK bioscience Exports Influenza Vaccine to Thailand, Entering Southern Hemisphere Market 2024-03-21 13:24
TreeFrog's Chief Scientific Officer & Co-founder, Maxime Feyeux, to present at The 23rd Congress of the Japanese Society for Regenerative Medicine (JSRM) 2024-03-21 07:30
Jiangsu Recbio Technology Co., Ltd. announced 2023 annual results report and latest progress 2024-03-21 00:22
Antengene Initiates Phase II Dose Expansion Study of Claudin 18.2 ADC ATG-022 in China and Australia 2024-03-20 20:30
Antennova Completes First Dosing Cohort for Anti-CD24 mAb, ATN-031, in the Phase I PERFORM Study 2024-03-20 20:30
Origin Agritech Announces Breakthrough in High-Yield Corn Production Through Gene Editing 2024-03-20 20:00
Innovent Announces 2023 Annual Results and Business Updates 2024-03-20 19:44
Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the Development of Transformational Therapies 2024-03-20 11:00
Antengene Publishes Preclinical Paper on PD-L1/4-1BB Bispecific Antibody ATG-101 in Renowned Oncology Journal Cancer Research 2024-03-20 08:30
SGO 2024 | The First Published Clinical Data of Nectin-4-Targeting ADC Developed by Mabwell in Cervical Cancer Demonstrates Its Outstanding Therapeutic Potential 2024-03-19 22:00
Samsung Medison and Bracco Imaging Forge Path with New Diagnostic Ultrasound Technology Agreement at ECR 2024 2024-03-19 18:00
LifeSpan Vision Ventures Invests in SENISCA 2024-03-19 17:00
Breakthrough in Treatment of Cervical High-Grade Squamous Intraepithelial Lesion: Release of Positive Results from Multicenter Phase III Global Clinical Study 2024-03-19 10:24
Sanyou Bio and BioGeometry join forces to create a next-generation Antibody Drug Discovery Platform driven by AIGC 2024-03-19 08:00
Innovent Announces Primary Endpoint Met in the Second Phase 2 Clinical Trial of IBI302 (anti-VEGF/complement) in Treating Neovascular Age-related Macular Degeneration (nAMD) 2024-03-19 08:00
Lunit Expands Presence in Europe: to Deliver AI-powered Cancer Screening Solution to France and Portugal 2024-03-18 21:00
1 8 9 10 11 12 413